Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M629Revenue $M102Net Margin (%)0Z-Score0
Enterprise Value $M551EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with OPTR

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OPTRMario Gabelli 2013-12-31 Sold Out $12.54 - $12.931
($12.71)
$ 12.781%Sold Out0
OPTRJean-Marie Eveillard 2013-12-31 Sold Out -0.01%$12.54 - $12.931
($12.71)
$ 12.781%Sold Out0
OPTRJean-Marie Eveillard 2013-09-30 Buy 0.01%$12.47 - $15.59
($13.24)
$ 12.78-4%New holding, 160100 sh.160,100
OPTRMario Gabelli 2013-09-30 Buy $12.47 - $15.59
($13.24)
$ 12.78-4%New holding, 20000 sh.20,000
OPTRGeorge Soros 2011-09-30 Sold Out -0.0017%$6.96 - $16.87
($11.28)
$ 12.7813%Sold Out0
OPTRGeorge Soros 2011-06-30 Buy $11.82 - $14.51
($12.98)
$ 12.78-2%New holding, 10200 sh.10,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OPTR is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


OPTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LICHTINGER PEDROFormer CEO 2013-04-08Sell148,000$14.69-13 view
LICHTINGER PEDROCEO and President 2012-11-08Buy11,000$9.0840.75 view
CHANG JOSEPH YDirector 2012-06-11Sell3,461$15.3-16.47 view
ALTIG ANTHONY EDirector 2011-08-09Buy5,000$7.4471.77 view
LICHTINGER PEDROCEO and President 2011-08-04Buy25,000$8.9842.32 view
CHANG JOSEPH YDirector 2010-05-12Sell8,076$11.758.77 view
Che Tessie MCOO and SVP 2009-12-29Buy18,000$10.8318.01 view
Chang Michael NCEO and President 2009-12-29Buy18,000$10.8318.01 view
Shue Youe KongVP, Clinical Development 2009-12-02Buy3,000$10.9916.29 view
Chang Michael NCEO and President 2009-11-25Buy15,000$11.5210.94 view

Press Releases about OPTR :

    Quarterly/Annual Reports about OPTR:

    News about OPTR:

    Articles On GuruFocus.com
    Weekly CEO Sells Highlight: Optimer Pharmaceuticals, ReachLocal, Tractor Supply, and RF Industries Apr 14 2013 
    Optimer Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
    Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
    Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 04 2010 
    Optimer Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
    Weekly CEO Buy Highlights: Helix Energy Solutions Group Inc, Optimer Pharmaceuticals Inc, Keithley I Jan 02 2010 
    Optimer Pharmaceuticals Inc. (OPTR) COO and SVP Tessie M Che buys 18,000 Shares Dec 29 2009 
    Optimer Pharmaceuticals Inc. (OPTR) CEO Michael N Chang buys 18,000 Shares Dec 29 2009 
    Weekly CEO Buys Highlight: Optimer Pharmaceuticals Inc, MBIA Inc, Endeavour International Corp, Dana Dec 04 2009 
    Weekly CEO Buys Highlight: Prospect Capital Corp, CONSTELLATION ENERGY, Optimer Pharmaceuticals Inc, Nov 30 2009 

    More From Other Websites
    FDA approves Cubist antibiotic for skin infections Jun 20 2014
    FDA approves Cubist antibiotic for skin infections Jun 20 2014
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Oct 24 2013
    Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals Oct 24 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Oct 23 2013
    Cubist Pharma Misses on Earnings and Revenues in Q3 Oct 23 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events Oct 15 2013
    Stellar Biotechnologies Appoints Tessie Che, Ph.D. to Board of Directors Sep 25 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 18 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Sep 16 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 13 2013
    Hart-Scott-Rodino waiting period expires for Cubist acquisition of Optimer Sep 13 2013
    How Cellceutix Acquired A Next Generation Antibiotic For Pennies On The Dollar Sep 12 2013
    Cubist Pharma Prices Senior Notes Sep 10 2013
    Scientific Conferences Create Buzz And Move Biotech Stocks: Michael King Sep 06 2013
    Voluntary Recall at Cubist Pharma Aug 30 2013
    OPTIMER PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 22 2013
    Still Neutral on Cubist Pharma Aug 20 2013
    OPTIMER PHARMACEUTICALS INC Financials Aug 15 2013
    Cubist Pharmaceuticals' Strategic Acquisitions Are Great For Investors Aug 14 2013

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide